Mental Processes for Rating Pain Intensity

This new study builds on the principal investigator's earlier studies to improve communication about pain. The research team seeks to better understanding of the mental processes needed to rate pain.

Study Overview

• Status: Enrolling by invitation
• Conditions: Pain
• Intervention / Treatment: Other: observational

• Study Type: Observational
• Enrollment (Estimated): 44

Contacts and Locations

Study Locations

• United States
  • Missouri
    • Columbia, Missouri, United States, 65211
      • University of Missouri

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Community sample

Description

General inclusion criteria:

• 18 years old or older;
• visited a HCP for treatment of a painful musculoskeletal condition within previous year;
• has usually felt, at least, "mild" musculoskeletal pain on most days of the last 3 months in multiple locations; and
• has felt variable musculoskeletal pain intensity during the last 3 months.

General exclusion criteria:

• past or current employment as a licensed healthcare provider;
• diagnosed with a cardiac arrhythmia;
• has a battery-powered implant in the neck, chest, abdomen, or spine (e.g., pacemaker);
• diagnosed with a neurological condition that causes uncontrolled movement (e.g., Parkinsonism, epilepsy, etc.);
• smokes cigarettes or vapes; (6) has abused substances during the last week; or
• allergic to skin adhesives.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
pain intensity	Pain intensity is the severity or magnitude of perceived pain. The researchers will use a 0 ("no pain")-10("pain as bad as you can imagine") numeric rating scale.	3 weeks

Collaborators and Investigators

• Sponsor: University of Missouri-Columbia

Study record dates

Study Major Dates

• Study Start (Actual): November 11, 2024
• Primary Completion (Estimated): May 20, 2025
• Study Completion (Estimated): May 20, 2025

Study Registration Dates

• First Submitted: November 3, 2024
• First Submitted That Met QC Criteria: February 11, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: February 11, 2025
• Last Verified: February 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Neurologic Manifestations; Pain
• Other Study ID Numbers: 2101603

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No